EMulate Therapeutics, Inc. (EMTX)

EMulate Therapeutics was planning to go public, but the IPO was withdrawn on Jul 31, 2024.

IPO Price Range

$4.00 - $6.00

Shares Offered

2,300,000

Deal Size

$11.50M

EMulate Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-28.02	-22.09	3.46
Depreciation & Amortization	0.77	1.04	0.59
Share-Based Compensation	-	6.04	3.6
Other Operating Activities	23.39	11.69	-10.83
Operating Cash Flow	-3.87	-3.32	-4.02
Share Issuance / Repurchase	-	1.64	0
Debt Issued / Paid	-	1.91	2.76
Financing Cash Flow	3.67	3.55	2.77
Net Cash Flow	-0.21	0.23	-1.25
Free Cash Flow	-3.88	-3.32	-4.02
Free Cash Flow Margin	-1520.39%	-1378.42%	-3555.75%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).